Evidence map›Paper›PMID 18651251›Full record

ArticleEndocrine pathology2008

Combined gangliocytoma and prolactinoma of the pituitary gland.

Shuji Mikami, Kaori Kameyama, Satoshi Takahashi, Kazunari Yoshida, Takeshi Kawase, Toshiaki Sano, Makio Mukai

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Endocrine pathology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Hypothalamic Endocrine Tumors: An Update.Journal of clinical medicine · 2019
    Review
  5. Growth hormone-secreting adenoma coexisted with gangliocytoma: a rare case.International journal of clinical and experimental pathology · 2018
    Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Shuji MikamiDivision of Diagnostic Pathology, Keio University Hospital, 35 Shinanomachi, Shinjuku-ku, Tokyo, Japan. mikami-s@sc.itc.keio.ac.jp
Kaori Kameyama
Satoshi Takahashi
Kazunari Yoshida
Takeshi Kawase
Toshiaki Sano
Makio Mukai
Keio University · JPKeio University Hospital · JPTokushima University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gangliocytomas of the pituitary gland are rare lesions that often occur in combination with pituitary adenomas, which are frequently associated with the hypersecretion of pituitary hormones, particularly growth hormones. We report a case of combined gangliocytoma and prolactinoma of the pituitary gland. A 49-year-old male presented with vertigo. Radiological examination revealed an intrasellar tumor with a suprasellar extension, which was removed via the trans-sphenoidal approach. Histologically, the tumor was composed of adenoma cells, mature ganglion cells and cells with features intermediate between those of adenoma cells and ganglion cells (intermediate cells). Immunohistochemical analysis revealed the ganglion cells and intermediate cells as well as adenoma cells to be positive for prolactin. No growth hormone-positive tumor cells were observed. The ganglion cells were positive for synaptophysin and neurofilament. The findings in this case are discussed in relation to hypotheses proposed for histogenesis, and the presence of intermediate cells supports three hypotheses. The first is that adenoma cells transform into ganglion cells, and the second is that both components originate from the embryonal pituitary cell rests, showing intermediate features between ganglion cells and adenoma cells. The last is that their common origin may be the same stem/progenitor cells in normal adult pituitaries.

Indexed as

Coloring AgentsEosine Yellowish-(YS)Fluorescent DyesGanglioneuromaHeadacheHematoxylinHumansImmunohistochemistryMagnetic Resonance ImagingMaleMiddle AgedParaffin EmbeddingPituitary HormonesPituitary NeoplasmsProlactinomaTissue FixationColoring AgentsEosine Yellowish-(YS)Fluorescent DyesHematoxylinPituitary Hormones

Identifiers

PMID18651251
OpenAlexW1985439889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.